|
Suppliers for CAS
113852-37-2
|
Properties | | CAS |
113852-37-2 | | Formula |
C8H14N3O6P |
|
|
14 Registered suppliers
Simagchem Corporation
P.R.China
Amadis Chemical Company Limited
P.R.China
More details are to be found here
H&Z Industry Co.,Ltd
P.R.China
More details are to be found here
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C8H14N3O6P Molecular Weight: 279.187021 HS Code: 2933599550
More details are to be found here
Guangzhou Topwork Chemical Co., Ltd.
P.R.China
Molecular Formula: C8H14N3O6P Molecular Weight: 279.187021 HS Code: 2933599550
More details are to be found here
Hangzhou Zhongqi Chem Co., Ltd
P.R.China
Molecular Formula: C8H14N3O6P Molecular Weight: 279.187021 HS Code: 2933599550
More details are to be found here
Finetech Industry Limited
P.R.China
More details are to be found here
Skyrun Industrial Co., Ltd.
P.R.China
More details are to be found here
NewCan Biotech Limited
P.R.China
More details are to be found here
BOC Sciences
USA
Description : Cidofovir is inhibitory to CMV plaque formation even when added to the cells at 48 hr post infection with IC50 of 0.9 μg/mL for Davis and 1.6 μg/mL for AD-169 strains,respectively. - Molecular Weight :279.19
- Boiling Point :609.5±65.0°C (Predicted)
- Melting Point :260°C (dec.)
- Purity :≥98% by HPLC
Molecular Formula : C8H14N3O6P Canonical SMILES : C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O InChI : InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1
InChIKey :
VWFCHDSQECPREK-LURJTMIESA-N
Solubility :
Soluble in Deionized Water (≥5 mg/mL, Warmed)
Appearance :
Powder
Storage : Store at -20°C
Synonyms :
Vistide; HPMPC; (S)-HPMPC; Cidofovir anhydrous; GS-504; GS 504; GS504; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
More details are to be found here
Xiamen Equation Chemical Co.,Ltd
P.R.China
Description : Cidofovir is inhibitory to CMV plaque formation even when added to the cells at 48 hr post infection with IC50 of 0.9 μg/mL for Davis and 1.6 μg/mL for AD-169 strains,respectively. - Molecular Weight :279.19
- Boiling Point :609.5±65.0°C (Predicted)
- Melting Point :260°C (dec.)
- Purity :≥98% by HPLC
Molecular Formula : C8H14N3O6P Canonical SMILES : C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O InChI : InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1
InChIKey :
VWFCHDSQECPREK-LURJTMIESA-N
Solubility :
Soluble in Deionized Water (≥5 mg/mL, Warmed)
Appearance :
Powder
Storage : Store at -20°C
Synonyms :
Vistide; HPMPC; (S)-HPMPC; Cidofovir anhydrous; GS-504; GS 504; GS504; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
More details are to be found here
AK Scientific, Inc.
USA
Description : Cidofovir is inhibitory to CMV plaque formation even when added to the cells at 48 hr post infection with IC50 of 0.9 μg/mL for Davis and 1.6 μg/mL for AD-169 strains,respectively. - Molecular Weight :279.19
- Boiling Point :609.5±65.0°C (Predicted)
- Melting Point :260°C (dec.)
- Purity :≥98% by HPLC
Molecular Formula : C8H14N3O6P Canonical SMILES : C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O InChI : InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1
InChIKey :
VWFCHDSQECPREK-LURJTMIESA-N
Solubility :
Soluble in Deionized Water (≥5 mg/mL, Warmed)
Appearance :
Powder
Storage : Store at -20°C
Synonyms :
Vistide; HPMPC; (S)-HPMPC; Cidofovir anhydrous; GS-504; GS 504; GS504; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
More details are to be found here
Chemos GmbH & Co. KG
Germany
Description : Cidofovir is inhibitory to CMV plaque formation even when added to the cells at 48 hr post infection with IC50 of 0.9 μg/mL for Davis and 1.6 μg/mL for AD-169 strains,respectively. - Molecular Weight :279.19
- Boiling Point :609.5±65.0°C (Predicted)
- Melting Point :260°C (dec.)
- Purity :≥98% by HPLC
Molecular Formula : C8H14N3O6P Canonical SMILES : C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O InChI : InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1
InChIKey :
VWFCHDSQECPREK-LURJTMIESA-N
Solubility :
Soluble in Deionized Water (≥5 mg/mL, Warmed)
Appearance :
Powder
Storage : Store at -20°C
Synonyms :
Vistide; HPMPC; (S)-HPMPC; Cidofovir anhydrous; GS-504; GS 504; GS504; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
More details are to be found here
BuGuCh & Partners
Germany
Description : Cidofovir is inhibitory to CMV plaque formation even when added to the cells at 48 hr post infection with IC50 of 0.9 μg/mL for Davis and 1.6 μg/mL for AD-169 strains,respectively. - Molecular Weight :279.19
- Boiling Point :609.5±65.0°C (Predicted)
- Melting Point :260°C (dec.)
- Purity :≥98% by HPLC
Molecular Formula : C8H14N3O6P Canonical SMILES : C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O InChI : InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1
InChIKey :
VWFCHDSQECPREK-LURJTMIESA-N
Solubility :
Soluble in Deionized Water (≥5 mg/mL, Warmed)
Appearance :
Powder
Storage : Store at -20°C
Synonyms :
Vistide; HPMPC; (S)-HPMPC; Cidofovir anhydrous; GS-504; GS 504; GS504; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
More details are to be found here
Detailed information on the suppliers of
Cidofovir |
details
details